about
Antimalarial therapy selection for quinolone resistance among Escherichia coli in the absence of quinolone exposure, in tropical South AmericaArtemether-lumefantrine versus dihydroartemisinin-piperaquine for treating uncomplicated malaria: a randomized trial to guide policy in Uganda.Syndromic diagnosis of malaria in rural Sierra Leone and proposed additions to the national integrated management of childhood illness guidelines for fever.Financial implications of refugee malaria: the impact of pre-departure presumptive treatment with anti-malarial drugsCost of increasing access to artemisinin combination therapy: the Cambodian experience.Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies.
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Making antimalarial agents available in Africa.
@en
type
label
Making antimalarial agents available in Africa.
@en
prefLabel
Making antimalarial agents available in Africa.
@en
P356
P1476
Making antimalarial agents available in Africa.
@en
P2093
Dean T Jamison
Hellen Gelband
P304
P356
10.1056/NEJMP058168
P407
P577
2005-07-06T00:00:00Z